Whereas this year’s American Society of Clinical Oncology Annual Meeting (ASCO 2018) boasted two Phase III studies and four Phase II studies with notable results in hepatocellular carcinoma (HCC), the trend did not continue to the European Society for Medical Oncology Conference (ESMO 2018), held in Münich, Germany between October 19-23, 2018. The focus for this years ESMO was mostly on biliary-tract cancers (BTC). Welcome to the hepatobiliary track of ESMO 2018.
Updates from the ESMO 2018 Annual Meeting (#ESMO18)
The ESMO 2018 Annual Meeting will be held from October 19 to 23 in Munich, Germany. MediPaper will summarise the key papers from the #ESMO18, including the ALESIA, ARTIC, ALEX, ASCEND-3, ALTA-1L, and IMpower130 studies.
Other specific interests this year go to the ESMO 2018 hepatocellular cancer track and the breast cancer track.